Given that PRMT2 has the potential to repress inflammation and increase cholesterol efflux pathways, we hypothesized that the reduced expression of PRMT2 by high glucose is a key determinant of impaired atherosclerosis regression in diabetes. The gene discussed is PRMT2; the disease is atherosclerosis.